NO930739L - Substituerte fenylkinazolinderivater - Google Patents
Substituerte fenylkinazolinderivaterInfo
- Publication number
- NO930739L NO930739L NO93930739A NO930739A NO930739L NO 930739 L NO930739 L NO 930739L NO 93930739 A NO93930739 A NO 93930739A NO 930739 A NO930739 A NO 930739A NO 930739 L NO930739 L NO 930739L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- alkyl
- alkoxy
- trifluoromethyl
- substituted phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Substituerte fenylkinazolinderivater med formel I hvor RI er hydrogen, alkyl, alkoksy, trifluormetyl, fluor eller klor, Rs og R2 er uavhengig sv hverandre hydrogen, alkyl, alkoksy, trifluormetyl, fluor eller klor, R- er hydrogen eller alkyl, A og B er enten sammen en gruppe med formelen -C (R-R,)C(R6R7)-S- hvor R4 er hydrogen, alkyl som eventuelt er mono-, di- eller trisubstituert med halogen med atomnummer 9-25, eller fenyl som eventuelt er T.ono- eller disubstituert med alkyl, alkoksy eller ha loger, med atomnummer 9 - 35, Ro er hydroksy og Rt er hydrogen eller R, og Ré danner sammen en dobbelt (r.)-binding, og -;., er hydrogen eller alkyl, eller A er hydrogen og 3 er en gruppe -S-CHR-' -R,c, hvor R,' er hydrogen eller alkyl og R!C er alkyl, alkenyl eller COOR;I hvor R:: er resten av en estergruppe, med den betingelse at RIO er annet enn metyl når R-,' er et hydrogen, RE er hydrogen, alkyl, alkoksy, tri fluormetyl eller halogen med atomnummer 9-35. Fremstilling av forbindelsene er beskrevet. Forbindelsene har terapeutisk aktivitet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84512392A | 1992-03-03 | 1992-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO930739D0 NO930739D0 (no) | 1993-03-01 |
NO930739L true NO930739L (no) | 1993-09-06 |
Family
ID=25294463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93930739A NO930739L (no) | 1992-03-03 | 1993-03-01 | Substituerte fenylkinazolinderivater |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0564397A1 (no) |
JP (1) | JPH0649076A (no) |
KR (1) | KR930019642A (no) |
CN (1) | CN1076445A (no) |
AU (1) | AU3387593A (no) |
CA (1) | CA2090635A1 (no) |
CZ (1) | CZ30293A3 (no) |
FI (1) | FI930922A (no) |
HU (1) | HUT63629A (no) |
IL (1) | IL104892A0 (no) |
NO (1) | NO930739L (no) |
NZ (1) | NZ247032A (no) |
TW (1) | TW227563B (no) |
ZA (1) | ZA931516B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1655289A1 (en) * | 2004-11-04 | 2006-05-10 | Embl | Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
ME02297B (me) * | 2011-06-10 | 2016-02-20 | Chiesi Farm Spa | Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora |
CN104119231A (zh) * | 2013-04-27 | 2014-10-29 | 重庆华邦制药有限公司 | 二苯甲胺类化合物的制备方法及中间体 |
EP3102567B1 (en) * | 2014-02-04 | 2019-07-17 | University of Tennessee Research Foundation | Inhibitors of paxillin function and related compositions and methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1242863A (en) * | 1968-05-10 | 1971-08-18 | Pharmacia As | 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF |
DE3734909A1 (de) * | 1987-10-15 | 1989-04-27 | Boehringer Ingelheim Kg | Verwendung von oxochinazolinderivaten bei der behandlung der hyperlipidaemie |
-
1993
- 1993-02-26 EP EP93810142A patent/EP0564397A1/en not_active Withdrawn
- 1993-02-26 HU HU9300556A patent/HUT63629A/hu unknown
- 1993-03-01 JP JP5062508A patent/JPH0649076A/ja active Pending
- 1993-03-01 IL IL104892A patent/IL104892A0/xx unknown
- 1993-03-01 CZ CZ93302A patent/CZ30293A3/cs unknown
- 1993-03-01 NZ NZ247032A patent/NZ247032A/en unknown
- 1993-03-01 NO NO93930739A patent/NO930739L/no unknown
- 1993-03-01 AU AU33875/93A patent/AU3387593A/en not_active Abandoned
- 1993-03-01 CA CA002090635A patent/CA2090635A1/en not_active Abandoned
- 1993-03-02 FI FI930922A patent/FI930922A/fi not_active Application Discontinuation
- 1993-03-02 KR KR1019930002998A patent/KR930019642A/ko not_active Application Discontinuation
- 1993-03-02 CN CN93102010A patent/CN1076445A/zh active Pending
- 1993-03-03 ZA ZA931516A patent/ZA931516B/xx unknown
- 1993-03-04 TW TW082101580A patent/TW227563B/zh active
Also Published As
Publication number | Publication date |
---|---|
ZA931516B (en) | 1994-09-03 |
KR930019642A (ko) | 1993-10-18 |
TW227563B (no) | 1994-08-01 |
HU9300556D0 (en) | 1993-05-28 |
CZ30293A3 (en) | 1993-12-15 |
EP0564397A1 (en) | 1993-10-06 |
JPH0649076A (ja) | 1994-02-22 |
FI930922A0 (fi) | 1993-03-02 |
CA2090635A1 (en) | 1993-09-04 |
CN1076445A (zh) | 1993-09-22 |
HUT63629A (en) | 1993-09-28 |
AU3387593A (en) | 1993-09-09 |
NO930739D0 (no) | 1993-03-01 |
FI930922A (fi) | 1993-09-04 |
IL104892A0 (en) | 1993-07-08 |
NZ247032A (en) | 1994-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940563D0 (no) | Substituerte benzoylquanidiner, fremgangsmåter for fremstilling av dem, deres anvendelse som medikament eller diagnostikum, samt medikamenter inneholdende dem | |
NO952854L (no) | 1-arylpyrimidin-derivater | |
FR2396749A1 (fr) | Analogues de prostacycline | |
SE8302464L (sv) | Aromatiskt alkanderivat samt sett for framstellning derav | |
NO167088C (no) | Nye 5-alkoxy-2,4 diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen. | |
NO930739L (no) | Substituerte fenylkinazolinderivater | |
NO964053L (no) | Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
FR2445330A1 (fr) | Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament | |
MY101880A (en) | Benzoylphenylureas, the preparation thereof and the use thereof in pest control. | |
ES8505975A1 (es) | Procedimiento para la produccion de s,s-dioxidos de 3-acilamino-benzoisotiazol | |
ZA891241B (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
DK287282A (da) | Fremgangsmaade til fremstilling af adamantylethylaminer | |
MX9204457A (es) | Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos. | |
DE3788149D1 (de) | Prostazyklin-(PGI2)-Analoge. | |
IE40727L (en) | Aralkylamines | |
MX9602841A (es) | Benzoilguanidinas sustituidas con fluoroalquilo en la posicion 4, un procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como un medicamento que las contiene. | |
DK455285A (da) | 2-pyridin-thiolderivater | |
NO943861L (no) | Trisyklisk forbindelse til bruk som tachykinin-antagonist | |
EP0252875A3 (en) | Microbicidal agent | |
ES8304111A1 (es) | Procedimiento para la preparacion de 2,3-dihidro piranos. | |
ZA906446B (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
SE9402596D0 (sv) | Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa | |
GB2071097B (en) | 1-(acylamino-aryloxy)-3-alkynylamino-propan-2-ols processes for their preparation and pharmaceutical compositions containing them | |
FR2417985A1 (fr) | Nouvelle association medicamenteuse a base d'un derive de la dibenzo(b,e) (1,4)diazepine-11-one | |
DK0455899T3 (da) | Prostaglandin I-analog |